Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Bonet Beltrán, Marta ^a,b   Roth, Arnaud D ^b   Mentha, Gilles ^b   Allal, Abdelkarim S ^b,c  

^a Brain   (Spain)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c Radiation Oncology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT;

ABDOMINAL PAIN; ADULT; AGED; ANASTOMOSIS STENOSIS; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; BILIARY TRACT SURGERY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CHEMORADIOTHERAPY; CHOLECYSTECTOMY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; DIARRHEA; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; EXTRAHEPATIC BILIARY TRACT CANCER; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GALLBLADDER CANCER; GASTROINTESTINAL TOXICITY; HUMAN; LIVER CANCER; LIVER METASTASIS; LUNG CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREATICODUODENECTOMY; PARTIAL GASTRECTOMY; PERITONEUM CANCER; PERITONEUM METASTASIS; POSTOPERATIVE CARE; RADIATION DOSE; RADIATION SICKNESS; RETROSPECTIVE STUDY; SKIN METASTASIS; VOMITING; ABDOMINAL SURGERY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BILE DUCT TUMOR; EVALUATION; HEPATIC DUCT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; CHEMOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; CISPLATIN; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIER ESTIMATE; LEUCOVORIN; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES;

EID: 79959462204     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-267     Document Type: Article

References (33)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-917. 10.1002/ijc.25516, 21351269.
2. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002, 3(2):10.
3. Jarnagin WR, Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis 2004, 24:189-99. 10.1055/s-2004-828895, 15192791.
4. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005, 128:1655-67. 10.1053/j.gastro.2005.03.040, 15887157.
5. de Castro SM, van Heek NT, Kuhlmann KF, Busch OR, Offerhaus GJ, van Gulik TM, Obertop H, Gouma DJ. Surgical management of neoplasms of the ampulla of Vater: local resection or pancreatoduodenectomy and prognostic factors for survival. Surgery 2004, 136:994-1002. 10.1016/j.surg.2004.03.010, 15523392.
6. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg 2008, 196:160-9. 10.1016/j.amjsurg.2007.07.033, 18466862.
7. Lee JH, Whittington R, Williams NN, Berry MF, Vaughn DJ, Haller DG, Rosato EF. Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol Biol Phys 2000, 47:945-53. 10.1016/S0360-3016(00)00537-X, 10863064.
8. Czito BG, Anscher MS, Willett CG. Radiation therapy in the treatment of cholangiocarcinoma. Oncology (Williston Park) 2006, 20:873-84.
9. Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, Wagman R, Blumgart LH, Fong Y. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003, 98:1689-700. 10.1002/cncr.11699, 14534886.
10. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999, 230:776-82. discussion 782-4, 10.1097/00000658-199912000-00006, 1420941, 10615932.
11. Radiation Therapy Oncology Group Adverse events reporting. Radiation Therapy Oncology Group., http://www.rtog.org/ResearchAssociates/AdverseEventReporting.aspx
12. Itoh H, Nishijima K, Kurosaka Y, Takegawa S, Kiriyama M, Dohba S, Kojima Y, Saitoh Y. Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder. Dig Dis Sci 2005, 50:2231-42. 10.1007/s10620-005-3040-8, 16416167.
13. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 2000, 232:557-69. 10.1097/00000658-200010000-00011, 1421188, 10998654.
14. Murakami Y, Uemura K, Hayasidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T. Indication for postoperative adjuvant therapy in biliary carcinoma based on analysis of recurrence and survival after surgical resection. Dig Dis Sci 2009, 54:1360-4. 10.1007/s10620-008-0492-7, 18975086.
15. World Health Organization Statistical Classification of Diseases and Related Health Problems. 10th Revision. v.3, World Health Organization., http://www3.who.int/icd/vol1htm2003/fr-icd.htm
16. Palta M, Willett C, Patel P, Uronis H, Tyler D, Czito B. Carcinoma of the Ampulla of Vater: Patterns of Failure after Resection and Possible Benefit of Adjuvant Radiotherapy. Int J Radiat Oncol Biol Phys 2010, 78(suppl 3):195-196.
17. Mojica P, Smith D, Ellenhorn J. Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol 2007, 96:8-13. 10.1002/jso.20831, 17516546.
18. Wang SJ, Fuller CD, Kim JS, Sittig DF, Thomas CR, Ravdin PM. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol 2008, 26:2112-7. 10.1200/JCO.2007.14.7934, 18378567.
19. Zaydfudim V, Feurer ID, Wright JK, Pinson CW. The impact of tumor extent (T stage) and lymph node involvement (N stage) on survival after surgical resection for gallbladder adenocarcinoma. HPB (Oxford) 2008, 10:420-7.
20. Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley S, Pisters PW, Evans D, Abdalla EK, Thomas MB, Das P, Wistuba II, Krishnan S, Vauthey JN. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 2008, 15:3147-56. 10.1245/s10434-008-9998-7, 18754070.
21. Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. Int J Radiat Oncol Biol Phys 2008, 70:735-43. 10.1016/j.ijrobp.2007.07.2327, 17980502.
22. Sikora SS, Balachandran P, Dimri K, Rastogi N, Kumar A, Saxena R, Kapoor VK. Adjuvant chemo-radiotherapy in ampullary cancers. Eur J Surg Oncol 2005, 31:158-63. 10.1016/j.ejso.2004.08.013, 15698732.
23. Gerhards MF, van Gulik TM, González D, Rauws EA, Gouma DJ. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 2003, 27:173-9.
24. Hughes MA, Frassica DA, Yeo CJ, Riall TS, Lillemoe KD, Cameron JL, Donehower RC, Laheru DA, Hruban RH, Abrams RA. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys 2007, 68:178-82. 10.1016/j.ijrobp.2006.11.048, 17276614.
25. Kim RD, Kundhal PS, McGilvray ID, Cattral MS, Taylor B, Langer B, Grant DR, Zogopoulos G, Shah SA, Greig PD, Gallinger S. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg 2006, 202:112-9. 10.1016/j.jamcollsurg.2005.08.002, 16377504.
26. Kim S, Kim SW, Bang YJ, Heo DS, Ha SW. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 2002, 54:414-9. 10.1016/S0360-3016(02)02952-8, 12243816.
27. Oh D, Lim do H, Heo JS, Choi SH, Choi DW, Ahn YC, Park W, Huh SJ. The role of adjuvant radiotherapy in microscopic tumor control after extrahepatic bile duct cancer surgery. Am J Clin Oncol 2007, 30:21-5. 10.1097/01.coc.0000245467.97180.78, 17278890.
28. Kobayashi K, Tsuji A, Morita S, Horimi T, Shirasaka T, Kanematsu T. A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma. BMC Cancer 2006, 6:121. 10.1186/1471-2407-6-121, 1483897, 16677397.
29. Czito BG, Hurwitz HI, Clough RW, Tyler DS, Morse MA, Clary BM, Pappas TN, Fernando NH, Willett CG. Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 2005, 62:1030-4. 10.1016/j.ijrobp.2004.12.059, 15990005.
30. Kim MJ, Oh DY, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ. Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study. BMC Cancer 2008, 8:374. 10.1186/1471-2407-8-374, 2615782, 19091129.
31. Laurent S, Monsaert E, Boterberg T, Demols A, Borbath I, Polus M, Hendlisz A, de Hemptinne B, Mahin C, Scalliet P, Van Laethem JL, Peeters M. Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study. Ann Oncol 2009, 20:1369-74. 10.1093/annonc/mdp005, 19457936.
32. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T, . Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 2002, 95:1685-95. Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract.
33. Ben-David MA, Griffith KA, Abu-Isa E, Lawrence TS, Knol J, Zalupski M, Ben-Josef E. External-beam radiotherapy for localized extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 2006, 66:772-9. 10.1016/j.ijrobp.2006.05.061, 17011452.